Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease-Reference-Cited by-同舟云学术

Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

Published:2018-05-16 Issue:5 Volume:44 Page:837-849
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol.

Author:

Holper L^ORCID,Ben-Shachar D,Mann JJ

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/s41386-018-0090-0.pdf

Reference191 articles.

1. Bansal Y, Kuhad A. Mitochondrial dysfunction in depression. Curr Neuropharmacol. 2016;14:610–8.

2. Kato T. Neurobiological basis of bipolar disorder: mitochondrial dysfunction hypothesis and beyond. Schizophr Res. 2017;187:62–66.

3. Bergman O, Ben-Shachar D. Mitochondrial oxidative phosphorylation system (OXPHOS) deficits in schizophrenia: possible interactions with cellular processes. Can J Psychiatry. 2016;61:457–69.

4. Onyango I, Khan S, Bennett J. Mitochondria in the pathophysiology of Alzheimer’s and Parkinson’s diseases. Front Biosci. 2017;22:854–72.

5. Hroudová J, Fišar Z. Connectivity between mitochondrial functions and psychiatric disorders. Psychiatry Clin Neurosci. 2011;65:130–41.

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome analysis reveals the anti-Parkinson's activity of Mangiferin in zebrafish;Biomedicine & Pharmacotherapy;2024-10

2. The researcher's guide to selecting biomarkers in mental health studies;BioEssays;2024-09-11

3. The effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomized controlled clinical trial protocol;Frontiers in Nutrition;2024-08-21

4. Pharmacological mechanisms of puerarin in the treatment of Parkinson's disease: An overview;Biomedicine & Pharmacotherapy;2024-08

5. Alpha Synuclein Toxicity and Non-Motor Parkinson’s;Cells;2024-07-27